Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 4/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | BCHE | P06276 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
| ▸ | ATF4 | P18848 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23182908 | 0.91 | KDM4E (0.54) | TDP1MEN1KMT2AKDM4ESMN1; SMN2 | |
| SCHEMBL22627721 | 0.88 | ALDH1A1 (0.45) | TDP1MEN1KMT2ASMN1; SMN2CYP1A2 | |
| SCHEMBL23383744 | 0.87 | HTT (0.57) | TDP1MEN1KMT2AKDM4ESMN1; SMN2 | |
| SCHEMBL23383779 | 0.86 | MEN1 (0.50) | TDP1MEN1KMT2AKDM4ESMN1; SMN2 | |
| SCHEMBL23182750 | 0.86 | SMN1; SMN2 (0.55) | MEN1KMT2AKDM4ESMN1; SMN2CYP1A2 | |
| SCHEMBL23182881 | 0.85 | HDAC1 (0.61) | TDP1MEN1KMT2AKDM4ESMN1; SMN2 | |
| SCHEMBL23182732 | 0.85 | HTT (0.52) | MEN1KMT2AKDM4ESMN1; SMN2CYP1A2 | |
| SCHEMBL23384172 | 0.85 | MEN1 (0.49) | TDP1MEN1KMT2AKDM4ESMN1; SMN2 | |
| SCHEMBL23384162 | 0.85 | KMT2A (0.49) | TDP1MEN1KMT2AKDM4ESMN1; SMN2 | |
| SCHEMBL25962494 | 0.84 | KDM4E (0.53) | TDP1MEN1KMT2AKDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210093619-A1 | Chemical Compounds as ATF-4 Pathway Inhibitors | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2021-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210093619-A1 | Chemical Compounds as ATF-4 Pathway Inhibitors | ATF4, ATF1, XBP1 | TDP1 2441/4885MEN1 4697/4885KMT2A 2770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.